Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Leukemia & Lymphoma|December 29, 2004
Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndromeBruno Rotoli, Lucio Catalano, Maurizio Galderisi, et al.Cancers|March 6, 2021
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic BiomarkersRaffaele Di Francia, Stefania Crisci, Angela De Monaco, et al.European Journal of Haematology|July 15, 2011
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomasGaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, et al.The American Journal of Pathology|November 7, 2009
Expression of the brain transcription factor OTX1 occurs in a subset of normal germinal-center B cells and in aggressive Non-Hodgkin LymphomaDaniela Omodei, Dario Acampora, Filippo Russo, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2014
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphomaLuigi Aloj, Laura D'Ambrosio, Michela Aurilio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter studyDaniele Laszlo, Giovanna Andreola, Luigi Rigacci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trialChristian W Scholz, Antonello Pinto, Werner Linkesch, et al.British Journal of Haematology|June 29, 2011
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathyGaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, et al.British Journal of Haematology|November 22, 2011
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphomaGaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, et al.Oncotarget|August 6, 2016
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomasRenato Franco, Giosuè Scognamiglio, Elena Valentino, et al.Pageof 4